[go: up one dir, main page]

ES497974A0 - Procedimiento para la obtencion de un octapeptido ciclico - Google Patents

Procedimiento para la obtencion de un octapeptido ciclico

Info

Publication number
ES497974A0
ES497974A0 ES497974A ES497974A ES497974A0 ES 497974 A0 ES497974 A0 ES 497974A0 ES 497974 A ES497974 A ES 497974A ES 497974 A ES497974 A ES 497974A ES 497974 A0 ES497974 A0 ES 497974A0
Authority
ES
Spain
Prior art keywords
procedure
obtaining
cyclic octapeptide
octapeptide
cyclic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES497974A
Other languages
English (en)
Other versions
ES8204412A1 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis AG
Original Assignee
Ciba Geigy AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy AG filed Critical Ciba Geigy AG
Publication of ES497974A0 publication Critical patent/ES497974A0/es
Publication of ES8204412A1 publication Critical patent/ES8204412A1/es
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/655—Somatostatins
    • C07K14/6555—Somatostatins at least 1 amino acid in D-form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/02—Drugs for disorders of the endocrine system of the hypothalamic hormones, e.g. TRH, GnRH, CRH, GRH, somatostatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S930/00—Peptide or protein sequence
    • Y10S930/01—Peptide or protein sequence
    • Y10S930/16—Somatostatin; related peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Endocrinology (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Diabetes (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
ES497974A 1979-12-21 1980-12-19 Procedimiento para la obtencion de un octapeptido ciclico Expired ES8204412A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH1140979 1979-12-21

Publications (2)

Publication Number Publication Date
ES497974A0 true ES497974A0 (es) 1982-05-01
ES8204412A1 ES8204412A1 (es) 1982-05-01

Family

ID=4373223

Family Applications (1)

Application Number Title Priority Date Filing Date
ES497974A Expired ES8204412A1 (es) 1979-12-21 1980-12-19 Procedimiento para la obtencion de un octapeptido ciclico

Country Status (13)

Country Link
US (1) US4358439A (es)
EP (1) EP0031303A3 (es)
JP (1) JPS5697259A (es)
KR (1) KR830004221A (es)
AU (1) AU535632B2 (es)
DD (1) DD155985A5 (es)
DK (1) DK543680A (es)
ES (1) ES8204412A1 (es)
FI (1) FI803935A7 (es)
IL (1) IL61774A0 (es)
NO (1) NO803883L (es)
PT (1) PT72241B (es)
ZA (1) ZA807970B (es)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE14226T1 (de) * 1981-12-24 1985-07-15 Ciba Geigy Ag Cyclische octapeptide und pharmazeutische praeparate davon, sowie verfahren zur herstellung derselben und ihre anwendung.
US4428942A (en) 1982-05-17 1984-01-31 The Salk Institute For Biological Studies Analogs of somatostatin
US4816438A (en) * 1984-08-31 1989-03-28 The Salk Institute For Biological Studies Insulin-selective somatostatin analogs
US5474980A (en) * 1984-10-04 1995-12-12 Monsanto Company Prolonged release of biologically active somatotropins
US5411951A (en) * 1984-10-04 1995-05-02 Monsanto Company Prolonged release of biologically active somatotropin
HUT42101A (en) * 1985-01-07 1987-06-29 Sandoz Ag Process for preparing stomatostatine derivatives and pharmaceutical compositions containing such compounds
DE3522638A1 (de) * 1985-06-25 1987-01-08 Diamalt Ag Neue somatostatin-derivate
US4798821A (en) * 1987-03-02 1989-01-17 Merck & Co., Inc. Antihypertensive therapy for diabetics
US5633263A (en) * 1989-04-26 1997-05-27 The Administrators Of The Tulane Educational Fund Linear somatostatin analogs
US5443815A (en) * 1991-11-27 1995-08-22 Diatech, Inc. Technetium-99m labeled peptides for imaging
US6183722B1 (en) 1991-11-27 2001-02-06 Diatide, Inc. Somatostatin analogs
US6022966A (en) * 1993-11-22 2000-02-08 Neorx Corporation Pretargeting methods and compounds
US6017512A (en) * 1992-06-23 2000-01-25 Diatide, Inc. Radiolabeled peptides
US5504069A (en) * 1993-02-11 1996-04-02 Biomeasure, Inc. Inhibition of trauma-induced tumor growth
US5897858A (en) 1994-02-03 1999-04-27 Schering-Plough Healthcare Products, Inc. Nasal spray compositions exhibiting increased retention in the nasal cavity
US6908903B1 (en) 1994-12-07 2005-06-21 Aletheon Pharmaceuticals, Inc. Cluster clearing agents
US6172045B1 (en) 1994-12-07 2001-01-09 Neorx Corporation Cluster clearing agents
US5597894A (en) * 1995-06-05 1997-01-28 The Louisiana State University Medical Center Foundation Multi-tyrosinated somatostatin analogs
US6841533B1 (en) 1995-12-07 2005-01-11 Peptor Limited Conformationally constrained backbone cyclized interleukin-6 antagonists
ES2202864T3 (es) 1997-05-13 2004-04-01 Societe De Conseils De Recherches Et D'applications Scientifiques S.A.S. Agonistas de la somatostatina para disminuir el peso corporal.
US6004928A (en) * 1997-05-13 1999-12-21 Biomeasure, Incorporated Method of treating hyperlipidemia
EP0981364B1 (en) * 1997-05-13 2006-03-01 Societe De Conseils De Recherches Et D'applications Scientifiques S.A.S. Method and compositions for treating hyperlipidemia
CA2289499C (en) * 1997-05-13 2010-02-23 Michael Anthony Cawthorne Somatostatin and somatostatin agonists for treating insulin insensitivity and syndrome x
US5968903A (en) * 1998-05-07 1999-10-19 Biomeasure, Incorporated Inhibition of H. pylori proliferation
ATE424414T1 (de) 2001-06-08 2009-03-15 Sod Conseils Rech Applic Chimere somatostatin-dopamin-analoga
EP1624884A4 (en) 2003-04-22 2009-08-05 Ipsen Pharma SOMATOSTATIN VECTORS
JP6869720B2 (ja) 2013-06-13 2021-05-12 アンチセンス セラピューティクス リミテッド 併用療法

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3875207A (en) * 1967-01-25 1975-04-01 Ciba Geigy Corp Process for the temporary protection of amino groups in peptide syntheses
US3944590A (en) * 1967-01-25 1976-03-16 Ciba-Geigy Corporation Process for the temporary protection of amino groups in peptide syntheses
US3725380A (en) * 1969-04-05 1973-04-03 Hoechst Ag Method of synthesizing peptides in the presence of a carbodiimide and a 1-hydroxy-benzotriazole
DE2202613C3 (de) * 1972-01-20 1974-06-20 Farbwerke Hoechst Ag, Vormals Meister Lucius & Bruening, 6000 Frankfurt Verfahren zur Herstellung von Peptiden
CH577464A5 (es) * 1972-09-22 1976-07-15 Ciba Geigy Ag
US4162248A (en) * 1976-10-14 1979-07-24 Merck & Co., Inc. Somatostatin analogs
IE47421B1 (en) * 1977-06-08 1984-03-07 Merck & Co Inc Somatostatin analogs,process for their preparation and pharmaceutical compositions containing them
US4118380A (en) * 1977-07-25 1978-10-03 Ayerst, Mckenna & Harrison Limited Decapeptide analogs of somatostatin
LU78191A1 (de) * 1977-09-28 1979-05-25 Ciba Geigy Ag Verfahren zur herstellung von neuen cyclopeptiden
US4190648A (en) * 1979-03-13 1980-02-26 Merck & Co., Inc. Peptides having somatostatin activity

Also Published As

Publication number Publication date
FI803935L (fi) 1981-06-22
IL61774A0 (en) 1981-01-30
EP0031303A3 (de) 1981-11-04
NO803883L (no) 1981-06-22
PT72241A (en) 1981-01-01
US4358439A (en) 1982-11-09
EP0031303A2 (de) 1981-07-01
JPS5697259A (en) 1981-08-05
ZA807970B (en) 1982-01-27
DD155985A5 (de) 1982-07-21
ES8204412A1 (es) 1982-05-01
AU535632B2 (en) 1984-03-29
KR830004221A (ko) 1983-07-09
AU6561280A (en) 1981-06-25
PT72241B (en) 1981-11-02
DK543680A (da) 1981-06-22
FI803935A7 (fi) 1981-06-22

Similar Documents

Publication Publication Date Title
ES497974A0 (es) Procedimiento para la obtencion de un octapeptido ciclico
ES493029A0 (es) Procedimiento para la obtencion de octapeptidos ciclicos
ES493633A0 (es) Procedimiento para la obtencion de muramilpeptidos
ES496848A0 (es) Procedimiento para la obtencion de azoliloxi-carboxil-n- oxiamidas
ES494131A0 (es) Un procedimiento para la preparacion de diariltiofenos.
ES493770A0 (es) Procedimiento para la obtencion de poliarilensulfuros
ES493330A0 (es) Procedimiento para la obtencion de nikkomicinas de efecto pesticida
ES491944A0 (es) Un procedimiento para la preparacion de tienamicinas.
ES495892A0 (es) Un procedimiento para la preparacion de metacroleina
ES493771A0 (es) Procedimiento para la obtencion de poliarilensulfuros
ES491835A0 (es) Un procedimiento para la preparacion de mono-y-di-esteres desacarosa.
ES489470A0 (es) Un procedimiento para la preparacion de 9-aminoalquilfluore-no
ES496424A0 (es) Un procedimiento para la preparacion de un hexapeptido ci- clico
AR224012A1 (es) Un procedimiento para la preparacion de nuevas fenoxiaminas heterociclicas sustituidas
ES490101A0 (es) Un procedimiento para obtener 2,6-diaminonebularinas
ES491370A0 (es) Un procedimiento para la preparacion de piridizinobenzodiazepinas
ES493506A0 (es) Un procedimiento para la preparacion de desacetil-cefalospo-rina c
ES520119A0 (es) Procedimiento para la obtencion de n-vinilacilaminas ciclicas.
ES490475A0 (es) Procedimiento para la obtencion de metilolaminotriazinas eteradas
ES490988A0 (es) Procedimiento para la obtencion de butirolactona
ES490022A0 (es) Un procedimiento para la preparacion de imidazobenzodiacepi-nas
ES490277A0 (es) Un procedimiento para la preparacion de aminoeteres.
ES488810A0 (es) Procedimiento para la obtencion de diazatriciclos
ES491662A0 (es) Un procedimiento para la preparacion de un pirazol cuaterna-rio
ES491136A0 (es) Un procedimiento para la preparacion de imidazo-piridinas.